Important Considerations for Clinical Development Programmes

Dr David Eckland has over 20 years in the biotech and pharma industry. He works on a consultancy basis for Quanticate providing Sponsors with an independent evaluation of a drug candidate from a safety and efficacy perspective, and evaluates the likely development path, risks and alternatives. He has written a very useful 8 page article on Important Considerations in Clinical Development Programmes.

For anyone embarking on the development of a new medicinal product this is definitely worth a read.

To receive a copy, please fill out the form.